Nichepharm - About the company
Nichepharm is a seed company based in Gurugram (India), founded in 2019. It operates as a Pharmaceutical contract development and manufacturing organization focused on pharmaceutical industry. Nichepharm has raised an undisclosed amount in funding. The company has 371 active competitors, including 16 funded and 92 that have exited. Its top competitors include companies like Aizant, Almac Group and Concord Biotech.
Company Details
Nichepharm Lifesciences is a leading contract development and manufacturing organization (CDMO) in the pharmaceutical industry, providing a range of services including injectable product development and manufacturing. With over 20 years of experience, the company has established a strong reputation for quality and reliability, serving clients globally. Its manufacturing units are specialized in producing a variety of injectable products, including liquid ampoules, vials, cartridges, and syringes.
- Website
- nichepharm.com
- Registered Address
- 401, BAANI, 1, GOLF COURSE ROAD SECTOR-56, Gurgaon, GURGAON, Haryana, India, 122011
Key Metrics
Founded Year
2019
Location
Gurugram, India
Stage
Seed
Latest Funding Round
Investors
Ranked
74th among 371 active competitors
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
232 as on Oct 31, 2024
Legal entities associated with Nichepharm
Nichepharm is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
NICHEPHARM LIFESCIENCES PRIVATE LIMITED CIN: U24230HR2019PTC083085 , India, Active | Oct 16, 2019 | $10M - $50M (As on Mar 31, 2025) | 247 (As on May 31, 2025) |
Sign up to download Nichepharm's company profile
Nichepharm's funding and investors
Nichepharm has raised funding over 1 round. Its latest funding round was a Seed round on Aug 19, 2024 for $*****. 1 investor participated in its latest round. Nichepharm has 1 institutional investor.
Here is the list of recent funding rounds of Nichepharm:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 19, 2024 | 2135859 | Seed | 8702529 | 4252295 | 8796353 | 3068881 |
Access funding benchmarks and valuations. Sign up today!View details of Nichepharm's funding rounds and investors
Nichepharm's founders and board of directors
Founder? Claim ProfileNichepharm's employee count trend
Nichepharm has 232 employees as of Oct 24. The total employee count is 16.0% more than what it was in Oct 23. Here is Nichepharm's employee count trend over the years:
Uncover Nichepharm's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Nichepharm's Competitors and alternates
Top competitors of Nichepharm include Aizant, Almac Group and Concord Biotech. Here is the list of Top 10 competitors of Nichepharm, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Company offering contract development services for small molecules | $16.8M | 60/100 | ||
2nd | Almac Group 2001, Craigavon (United Kingdom), Series D | CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development | $339M | 57/100 | |
3rd | Concord Biotech 2000, Ahmedabad (India), Public | CDMO focused on manufacturing API | - | 56/100 | |
4th |  Nucleus RadioPharma 2022, Rochester (United States), Series A | CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services | $72.1M | 54/100 | |
5th | Indoco Remedies 1947, Mumbai (India), Public | Provider of APIs manufacturing and formulation services | - | 54/100 | |
6th | Development and manufacturing of niche pharmaceutical products for the generic industry | $2.74M | 52/100 | ||
7th |  Wanbury Limited 1990, Mumbai (India), Public | Manufacturer of anti-diabetic drugs | - | - | 52/100 |
8th | Sabinsa 1988, East Windsor (United States), Unfunded | Manufacturing and marketing nutraceuticals, cosmeceuticals and fine chemicals | - | - | 52/100 |
9th | Turnkey solutions for drug development, manufacturing and regulatory approvals | - | 52/100 | ||
10th | Aptuit 2004, Greenwich (United States), Acquired | Pioneering drug discovery and development, accelerating concept to cure | $14.2M | 50/100 | |
74th | Nichepharm 2019, Gurugram (India), Seed | Pharmaceutical contract development and manufacturing organization focused on pharmaceutical industry | - | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Nichepharm's competitors? Click here to see the top ones
Nichepharm's Investments and acquisitions
Nichepharm has acquired 2 companies including Recipharm and Recipharm. Nichepharm has not made any investments as of now.Reports related to Nichepharm
Here is the latest report on Nichepharm's geography:
News related to Nichepharm
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Nichepharm
Explore our recently published companies
- Gallstone Clinic - Unfunded company
- Dosa Kitchen - Brattleboro based, 2014 founded, Unfunded company
- Dosa Dip - Artesia based, Unfunded company
- Amanda Murdoch - 2014 founded, Unfunded company
- Amanda Mullen - Unfunded company
- Galloway Real Estate - United States based, Unfunded company
